The National Account Director will own payer access and coverage strategy for assigned national and regional commercial payers, PBMs, Medicaid plans, Medicare, and integrated delivery networks. This is a field-based role responsible for securing appropriate coverage and reimbursement for Deramiocel, Capricor’s lead cell therapy for Duchenne muscular dystrophy. This individual will partner closely with Market Access leadership, Trade & Patient Services, Medical Affairs, HEOR, Sales, and Patient Advocacy to translate the Deramiocel value proposition into coverage decisions, medical policy positions that support timely, equitable patient access in a high-cost, rare-disease, medical-benefit market. The position will engage senior payer decision-makers, deliver compelling clinical and economic value stories, navigate medical-benefit dynamics unique to infused cell therapies, and feed payer intelligence back into Capricor’s launch and access strategy.